Work

217-OR: A Randomized Controlled Trial Comparing the Safety and Efficacy of IDegLira vs. Basal Bolus in Patients with Poorly Controlled Type 2 Diabetes and Very High HbA1c (>9%–15%) : IDegLira HIGH Trial

Year: 2022

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes

DOI: 10.2337/db22-217-or

Authors: RODOLFO J. GALINDO, BOBAK MOAZZAMI, MARIA F. SCIOSCIA, PRIYATHAMA VELLANKI, GEORGIA M. DAVIS, FRANCISCO J. PASQUEL, MAYA FAYFMAN, ALEXANDRA L. MIGDAL, JARROD SALING, GUILLERMO E. UMPIERREZ

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281612016

FWCI: 0.151

Cites:

Cited by: 1

Related to: 10